These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 9012640)
1. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy. Aguilar-Salinas CA; Hugh P; Barrett R; Pulai J; Zhu XL; Schonfeld G Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):72-82. PubMed ID: 9012640 [TBL] [Abstract][Full Text] [Related]
2. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates. Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202 [TBL] [Abstract][Full Text] [Related]
3. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene. Elias N; Patterson BW; Schonfeld G Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1309-15. PubMed ID: 10807747 [TBL] [Abstract][Full Text] [Related]
4. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males. Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353 [TBL] [Abstract][Full Text] [Related]
5. Physiologic mechanisms of action of lovastatin in nephrotic syndrome. Aguilar-Salinas CA; Barrett PH; Kelber J; Delmez J; Schonfeld G J Lipid Res; 1995 Jan; 36(1):188-99. PubMed ID: 7706943 [TBL] [Abstract][Full Text] [Related]
6. Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors ("statins") in familial combined hyperlipidemia. Schonfeld G; Aguilar-Salina C; Elias N Am J Cardiol; 1998 Feb; 81(4A):43B-46B. PubMed ID: 9526813 [TBL] [Abstract][Full Text] [Related]
7. ApoB-75, a truncation of apolipoprotein B associated with familial hypobetalipoproteinemia: genetic and kinetic studies. Krul ES; Parhofer KG; Barrett PH; Wagner RD; Schonfeld G J Lipid Res; 1992 Jul; 33(7):1037-50. PubMed ID: 1431583 [TBL] [Abstract][Full Text] [Related]
8. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia. Elias N; Patterson BW; Schonfeld G Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2714-21. PubMed ID: 10559016 [TBL] [Abstract][Full Text] [Related]
9. Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia. Parhofer KG; Barrett PH; Dunn J; Schonfeld G Clin Investig; 1993 Nov; 71(11):939-46. PubMed ID: 8312689 [TBL] [Abstract][Full Text] [Related]
10. Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production. Arad Y; Ramakrishnan R; Ginsberg HN J Lipid Res; 1990 Apr; 31(4):567-82. PubMed ID: 2351867 [TBL] [Abstract][Full Text] [Related]
11. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
15. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Venkatesan S; Cullen P; Pacy P; Halliday D; Scott J Arterioscler Thromb; 1993 Jul; 13(7):1110-8. PubMed ID: 8318511 [TBL] [Abstract][Full Text] [Related]
16. Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins. Vega GL; Krauss RM; Grundy SM J Intern Med; 1990 Feb; 227(2):81-94. PubMed ID: 2105373 [TBL] [Abstract][Full Text] [Related]
17. Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia. Tremblay AJ; Lamarche B; Cohn JS; Hogue JC; Couture P Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1101-6. PubMed ID: 16528005 [TBL] [Abstract][Full Text] [Related]
18. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Ordovas JM; Schaefer EJ Arterioscler Thromb Vasc Biol; 1997 May; 17(5):881-8. PubMed ID: 9157951 [TBL] [Abstract][Full Text] [Related]
19. Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans. Welty FK; Lichtenstein AH; Barrett PH; Jenner JL; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1807-10. PubMed ID: 10894821 [TBL] [Abstract][Full Text] [Related]
20. Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia. Vega GL; Grundy SM Arterioscler Thromb; 1993 Apr; 13(4):579-89. PubMed ID: 8466893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]